Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Return on Invested Capital (2021 - 2025)

Oncology Institute's Return on Invested Capital history spans 5 years, with the latest figure at 0.57% for Q4 2025.

  • For Q4 2025, Return on Invested Capital changed N/A year-over-year to 0.57%; the TTM value through Dec 2025 reached 0.57%, changed N/A, while the annual FY2025 figure was 0.45%, N/A changed from the prior year.
  • Return on Invested Capital reached 0.57% in Q4 2025 per TOI's latest filing, up from 0.63% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.67% in Q4 2022 to a low of 0.65% in Q2 2025.
  • Average Return on Invested Capital over 5 years is 0.32%, with a median of 0.51% recorded in 2023.
  • Peak YoY movement for Return on Invested Capital: skyrocketed 124bps in 2022, then tumbled -118bps in 2023.
  • A 5-year view of Return on Invested Capital shows it stood at 0.57% in 2021, then soared by 217bps to 0.67% in 2022, then crashed by -177bps to 0.51% in 2023, then decreased by -9bps to 0.56% in 2024, then fell by -3bps to 0.57% in 2025.
  • Per Business Quant, the three most recent readings for TOI's Return on Invested Capital are 0.57% (Q4 2025), 0.63% (Q3 2025), and 0.65% (Q2 2025).